1. Home
  2. BCAB vs GTI Comparison

BCAB vs GTI Comparison

Compare BCAB & GTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • GTI
  • Stock Information
  • Founded
  • BCAB 2007
  • GTI 2019
  • Country
  • BCAB United States
  • GTI Malaysia
  • Employees
  • BCAB N/A
  • GTI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • GTI
  • Sector
  • BCAB Health Care
  • GTI
  • Exchange
  • BCAB Nasdaq
  • GTI NYSE
  • Market Cap
  • BCAB 27.0M
  • GTI 28.2M
  • IPO Year
  • BCAB 2020
  • GTI N/A
  • Fundamental
  • Price
  • BCAB $0.32
  • GTI $0.13
  • Analyst Decision
  • BCAB Buy
  • GTI
  • Analyst Count
  • BCAB 2
  • GTI 0
  • Target Price
  • BCAB $1.00
  • GTI N/A
  • AVG Volume (30 Days)
  • BCAB 534.1K
  • GTI 12.6M
  • Earning Date
  • BCAB 05-13-2025
  • GTI 05-15-2025
  • Dividend Yield
  • BCAB N/A
  • GTI N/A
  • EPS Growth
  • BCAB N/A
  • GTI N/A
  • EPS
  • BCAB N/A
  • GTI N/A
  • Revenue
  • BCAB $11,000,000.00
  • GTI N/A
  • Revenue This Year
  • BCAB N/A
  • GTI N/A
  • Revenue Next Year
  • BCAB N/A
  • GTI N/A
  • P/E Ratio
  • BCAB N/A
  • GTI N/A
  • Revenue Growth
  • BCAB N/A
  • GTI N/A
  • 52 Week Low
  • BCAB $0.24
  • GTI $0.07
  • 52 Week High
  • BCAB $3.53
  • GTI $11.09
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 47.19
  • GTI 49.45
  • Support Level
  • BCAB $0.26
  • GTI $0.10
  • Resistance Level
  • BCAB $0.34
  • GTI $0.12
  • Average True Range (ATR)
  • BCAB 0.04
  • GTI 0.02
  • MACD
  • BCAB 0.00
  • GTI 0.01
  • Stochastic Oscillator
  • BCAB 58.00
  • GTI 74.07

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About GTI GRAPHJET TECHNOLOGY

Graphjet Technology is a company that owns state-of-the-art technology for the manufacture of artificial graphene and graphite, critical raw materials used in a variety of industries. The technology was developed through our collaboration with National University of Malaysia and Universiti Teknikal Malaysia Melaka. It produces artificial graphite and graphene from palm seed kernels, a waste product widely available in Malaysia and other countries that produce palm seed oil. Unlike mineral coal-based or petroleum-based graphite which is ultimately limited and must be mined and processed to produce commercial-grade graphite, our raw materials are renewable and effectively unlimited.

Share on Social Networks: